Week - 1 |
Introduction and definitions |
Week - 2 |
Bioavailability differences among oral dosage forms |
Week - 3 |
Pharmacokinetic parameters defining bioavailability |
Week - 4 |
Importance of disintegration time |
Week - 5 |
Effect of production variables of solid forms on bioavailability |
Week - 6 |
Bioavaliability of oral solutions |
Week - 7 |
Bioavailability of suspensions |
Week - 8 |
Bioavalability of immediate release tablets |
Week - 9 |
Bioavailability of long-acting tablets |
Week - 10 |
Bioavailability of inhalation products |
Week - 11 |
Bioavailability of capsules |
Week - 12 |
Bioavalability of emulsions |
Week - 13 |
Bioavailability of new drug delivery nanoparticular systems |
Week - 14 |
Discussion and evaluation |